Dr. Joseph M. Defrank Castro, MD

Dr. Defrank Castro practices at Saint Clare's Denville Hospital in Denville, New Jersey, part of Prime Healthcare Services.

Dr. Defrank Castro's NPI, 1801095864, was assigned on July 11, 2007. Dr. Defrank Castro holds New Jersey license 25MA09544000.

Dr. Defrank Castro's primary practice is Saint Clare's Denville Hospital, at 25 Pocono Road, Denville, NJ 07834 in Morris County. The practice phone is (973) 983-5569.

Dr. Defrank Castro's primary practice is Saint Clare's Denville Hospital in Denville, New Jersey, part of Prime Healthcare Services. Dr. Defrank Castro is also affiliated with Morristown Medical Center. The medical group on file is Internal Medicine of Morris County. Dmand AI also links Dr. Defrank Castro to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Defrank Castro practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Defrank Castro's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Defrank Castro's licenses on file in 2 states: New Jersey and New York.

CMS data shows 1,409 Medicare services from Dr. Defrank Castro across 5 procedure codes in 2024, for 557 Medicare patients. Medicare paid $122,668 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 557 Medicare patients who saw Dr. Defrank Castro in 2024. The largest group is 75 to 84, with 205 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Defrank Castro's median patient age at 69, with 47% women.

In 2024, Dr. Defrank Castro wrote 463 Medicare Part D claims for 221 patients. 87% of them were for generic drugs. CMS names the drug for 215 of them, across 12 drugs with 11 or more claims each, at $10,738 in total drug cost. In 2023, CMS named 79 claims across 5 drugs.

Dr. Defrank Castro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Defrank Castro from 3 drug and device companies from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $24.